Sensitivity of Salmonella cholerae-suis to different animal species complements by Mongar, Amy Patrice
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
1-1-1984
Sensitivity of Salmonella cholerae-suis to different
animal species complements
Amy Patrice Mongar
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital
Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital
Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Mongar, Amy Patrice, "Sensitivity of Salmonella cholerae-suis to different animal species complements" (1984). Retrospective Theses
and Dissertations. 18516.
https://lib.dr.iastate.edu/rtd/18516
Sensitivity of Salmonella cholerae-suis to different animal species 
complements 
by 
Amy Patrice Mongar 
A Thesis Submitted to the 
Graduate Faculty in Partial Fulfillment of the 
Requirements for the Degree of 
MASTER OF SCIENCE 
Department: Veterinary Microbiology and Preventive Medicine 
Major: Veterinary Microbiology 
Signatures have been redacted for privacy 
Iowa State University 
Ames, Iowa 
1984 
ii 
TABLE OF CONTENTS 
Page 
GENERAL INTRODUCTION 1 
PART 1 BACTERICIDAL EFFECTS OF CCMPLEMENT AGAINST 
SAIMONELLA CHOLERAE-SUIS AND ESCHERICHIA COLI HI 
INTRODUCTION 11 
MATERIALS AND METHODS 18 
RESULTS 21 
DISCUSSION 34 
CONCLUSIONS 41 
PART 2 REDUCTION OF HEMOLYTIC COMPLEMENT LEVELS BY 
SAIMONELLA CHOLERAE-SUIS AND ESCHERICHIA COLI 42 
INTRODUCTION 43 
MATERIALS AND METHODS 49 
RESULTS 57 
DISCUSSION 66 
CONCLUSIONS 73 
SUMMARY 74 
LITERATURE CITED 78 
ACKNCWLEDGEMENTS 8 6 
1 
GENERAL INTRODUCTION 
The study of complement (C) was initiated in the late 1800s when 
investigators observed the ability of fresh serum to kill bacteria. 
Since that time, the majority of C research has been involved with its 
effects on bacteria. The term alexin was given to the bactericidal 
activity of serum. Alexin was thought to be an enzyme because it was 
inactivated by heat. Pfeiffer and Bordet demonstrated that antibody 
was required for bacteriolysis by alexin. Ehrlich and Morgenroth used 
the term complement to describe the ability of enzymes present i_n 
normal serum to lyse red blood cells in conjunction with antibody 
(Osler 1976). Complement was not a single enzyme but a mixture of 
enzymes. Early attempts to understand the nature of C resulted in 
identification of four components. The results from later studies 
indicated that C was made up of nine components. Further work with 
the first C component indicated that it actually was a complex of 
three proteins, thus raising the component numbers to eleven. The 
discovery of the alternate C pathway and C inhibitors gave a total of 
nineteen components involved in the C system. 
Complement is activated by two major pathways, both of which are 
characterized by the formation of enzymes that cleave C components to 
produce new enzymes, initiating a cascade reaction. The classical 
pathway is activated by antigen-antibody complexes. When antibody 
binds to antigen, there is a conformational change in the antibody 
structure which exposes c receptor sites. Complement component Cl is 
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a complex made up of three individual molecules: Clq, Cls, and Clr. 
The Clq component of Cl binds to the antibody. The other two Cl 
components, Clr and Cls, are then also bound. Together, they produce 
Cl esterase. This enzyme cleaves C4 to produce Cl4, which in turn 
cleaves C2. The Cl42 enzyme is known as C3 convertase (Mayer 1973, 
Vogt 1974, Muller-Eberhard 1977, Fine 1981). 
The other major pathway of C activation is the alternate pathway. 
Pillemer et al. (1954) described a new serum protein, which they named 
properdin, and which reacted with zymosan (yeast cell wall 
polysaccharide) to inactivate C3. Further investigations have 
determined that two other factors, factors B and D, are also involved 
in the alternate pathway. A number of substances, such as zymosan, 
viruses, lipopolysaccharide (LPS), rabbit erythrocytes, aggregated and 
nonaggregated antibodies, and some gram-positive bacteria, are capable 
of activating the alternate pathway. Fearon (1979) attributed 
alternate C pathway activation to the presence of protected C3b 
receptor sites lacking in sialic acid. Sialic acid is required for an 
inhibitor, factor H, to degrade C3b. Substances that activate the 
alternate C pathway interact with native C3b or with C3 to produce 
C3b. Factor B is bound to C3b and is cleaved by factor D to form 
C3bBb, otherwise known as C3 convertase. Properdin acts to stabilize 
the complex (Fearon 1979, Fine 1981, Pangburn 1983). The enzyme C3 
convertase cleaves C3 to form C3a and C3b. The C3b fragment is bound 
to the enzyme to produce CS conver~~-e 
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The terminal sequence is identical for both pathways after the 
formation of G3 convertase. The component CS is cleaved by CS 
convertase to produce membrane-bound CSb and csa. The two cleavage 
products, C3a and CSa, are anaphylactic and chemotactic factors 
important in processes such as endotoxic shock and inflammation. The 
membrane-bound CSb binds C6. Then, C7 is bound by the CSbC6 complex. 
Once C7 is bound, ca binds to CSb, and in turn binds C9. Lysis of the 
membrane begins after ca is bound, and the addition of C9 accelerates 
the process (Fine 19al, Mayer 1973). 
An additional mechanism of classical pathway activation has been 
demonstrated. Lipopolysaccharide can directly interact with Cl, 
independent of antibody, to initiate the classical pathway. Loos et 
al. (1974) observed that LPS, specifically lipid A, bound the Clq 
portion of Cl. Further studies by Loos et al. (197a) indicated that 
serum Cl as well as activated Cl was bound by LPS. Morrison and Kline 
(1977) demonstrated that lipid A initiated the classical pathway 
independent of antibody, and the polysaccharide region of LPS 
activated the alternate pathway. Betz and Isliker (19al) confirmed 
that Cl bound to LPS, and demonstrated that LPS bound and activated 
precursor Cl, which was capable of cleaving C4 and initiating 
hemolytic and bactericidal activities. 
The elucidation of complement components and activation has arisen 
from studies of their bactericidal effects. Gram-negative bacteria 
have been the primary focus of these studies. The frequency of 
nosocomial gram-negative infections has been steadily increasing. 
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Increased hospitalization, surgery, and irnmunosuppressive drugs have 
contributed to the rise. A number of gram-negative bacteria are 
common in the intestinal tract and are considered normal flora. 
Pathogenic and virulent bacteria have developed resistance to both 
host and bacterial defenses. The presence of large concentrations of 
gram-negative bacteria in the intestine is controlled and balanced by 
host mechanisms. In addition, there are two major defenses against 
invasive bacteria, the mucosal-epithelial cell barrier and the hepatic 
reticulendothelial system. Despite this, there is continuous 
absorption of endotoxin from the intestine. Small amounts of 
endotoxin are constantly released as bacteria die or are killed. 
Increased blood levels of vasoactive substances, such as serotonin, 
norepinephrine, and histamine, enhance intestinal permeability. Other 
factors, such as the absence of food or bile, or the presence of milk, 
may enhance transmucosal transport (Mims 1982, Walker and Porvaznik 
1978, Walker 1978). 
Many of the effects of gram-negative infection can be attributed 
to endotoxin present on the bacterial cell wall. Endotoxin is a 
complex of lipopolysaccharide (LPS) with a protein component bound to 
it. The term endotoxin was first used by Richard Pfeiffer in 1892 
when he observed that cholera vibrios produced a toxin associa~ed with 
the bacterial cell that was unaffected when the bacteria were killed. 
Endotoxic activity was associated with the lipopolysaccharide 
component of gram-negative bacteria and was related to the O antigen 
of Salmonella by Andre Boivin. Walter Morgan separated purified O 
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antigen into three components: a polysaccharide component, a 
conjugated protein, and a lipid component (Westphal et al. 1981). 
Westphal obtained a pure, protein-free lipopolysaccharide which was 
pyrogenic by using a phenol-water extraction method. Further 
separation with acid yielded lipopolysaccharide split into 
polysaccharide arid lipid fractions. The lipid portion, lipid A, was 
responsible for endotoxic activity (Figure 1). 
Lipid A is a hydrophobic glucosamine disaccharide to which 
saturated fatty acids are attached (Figure 2). The polysaccharide 
component consists of the core oligosaccharide, which is characterized 
by unusual sugars such as 2 keto-3-deoxyoctonate and heptuloses, and 
the polysaccharide side chains. These side chains have repeating 
units of oligosaccharides and determine the o antigen specificity for 
each gram-negative strain (Stryer 1981, Westphal et al. 1981). 
, Damage to the intestine will increase the uptake of endotoxin. An 
endotoxemia as well as a bacteremia can develop when the barrier 
function of the intestinal wall is damaged, whether by kinins, poor 
peristaltic flow or from lysosomal enzymes resulting from injury. 
Jacob Fine (1972) injected normal rabbits and rabbits that had no 
gram-negative flora with lethal doses of endotoxin. The normal 
rabbits died, but the rabbits without gram-negative flora survived and 
had no traces of endotoxin in the liver. The livers of the normal 
rabbits contained more endotoxin than what was initially injected. 
Walker and Porvaznik (1978) used mice to investigate the route of 
endotoxin from the intestine to the liver. Their results indicated 
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that endotoxin-induced inflammation disrupted the tight junctions 
between epithelial cells, providing a channel for bacteria to enter 
the host tissues and become systemic. In this manner, endotoxemia can 
become self-sustaining and can produce fatal shock. The liver is the 
primary organ for endotoxin clearance and prevention of systemic 
infection. Endotoxin is carried by the portal vein from the 
intestinal tract to the liver. There fixed macrophages, or Kupfer 
cells, take up the endotoxin and degrade it. Bacteria and endotoxin 
can become systemic by dverwhelming the Kupfer cells with the 
introduction of large concentrations of material. Endotoxin may also 
be taken.up by the lymphatic system and become systemic when 
introduced to the venous system (Berry 1975, Walker 1978, Nolan 1979). 
The effects of lipopolysaccharide have been intensely studied for 
many years. Different methods of introducing LPS into a host have 
been used. Animal models as well as human models have been studied. 
Investigations into a variety of enzymes, cell systems and immune 
responses have been performed. 
Injection of endotoxin i.v. into cattle causes salivation, 
diarrhea, coughing, severe dyspnea and collapse. Neutropenia, 
lymphopenia and granulocytosis occur along with hel!Orrhages in the 
brain, heart and lung. Disseminated intravascular coagulation also 
occurs, preceded by a drop in fibrinogen levels (Thompson et al. 1974, 
Nagaraja et al. 1979). Injection of endotoxin into ponies does not 
cause diarrhea, but does induce transient arterial hypotension, 
neutropenia, and hyperglycemia. Respiratory and peripheral vascular 
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perfusion also occurs (Burrows and Cannon 1970). In goats, endotoxin 
causes biphasic fever, decreased plasma iron levels, neutropenia, and 
lymphopenia. Kurtz and Quast (1982) studied the effect of endotoxin 
on swine. The reactions of the swine were similar to those of cattle. 
The pigs fell into three groups: normal animals, animals with 
neurological disturbances, and animals with renal necrosis. 
Th~ classical animal model of endotoxic shock is the dog. 
Intravenous injection of lethal doses of endotoxin causes systemic 
hypotension, decreased cardiac output, and decreased central venous 
pressure. Bi- or mono-phasic fever and increased peripheral 
resistance occur, and there is formation of small thrombi which induce 
coagulation. The decreased perfusion causes tissue damage. 
Leukopenia and neutropenia followed by leukocytosis also occur. 
Platelets, leukocytes, and granulocytes have endotoxin receptors and 
are induced to release vasoactive substances such as histamine and 
serotonin. These substances trigger blood clotting, disseminated 
intravascular coagulation, and vascular collapse .(Hawiger et al. 1975,. 
Berry 1975, Muller-Berghause 1978, McNulty 1983). 
The production of many of these substances is induced by the 
interaction of LPS with complement. The cleavage products C3a and CSa 
are chemotactic factors for lymphocytes, neutrophils, and macrophages 
and anaphlylactic factors for mast cells and basophils. The C3b 
fragment acts as an opsonization factor with or without antibody. 
Although conflicting results from in vivo studies have cast some 
question on the significance of complement during infection, the high 
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in vitro bactericidal activity of complement and involvement with 
other systems qualify it as an integral part of the host .defense 
system. 
It was reported that complement varies in activity with each 
animal species, and that components from one species are often not 
interchangeable with components of another species. This study was 
performed to examine the bactericidal effect of complement on gram-
negative bacteria and the variation of such effects between animal 
species complements. Part 1 of this study was concerned with the 
bactericidal effects of complement with and without antibody on 
Salmonella cholerae-suis and Escherichia coli, and to determine if 
susceptibility varied with the animal species complement used. 
Bactericidal complement may kill bacteria by two major pathways. 
Differences in cation requirements were used as a tool for studying 
the pathways in Part 2 to determine which pathway was activated by 
suscept'ible bacterial strains. 
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Figure 1 The structure of lipopolysaccharide of Salmonella 
typhimurium (Nikaido and Nakoe 1979) 
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Figure 2 The structure of lipid A from Salmonella minnesota (Nikaido 
and Nakoe 1979) 
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PART 1 BACTERICIDAL EFFECTS OF COMPLEMENT AGAINST 
SAIMONELLA CHOLERAE-SUIS AND ESCHERICHIA COLI 
11 
INTRODUCTION 
A characteristic of gram-negative bacteria is the presence of 
lipopolysaccharide (LPS) in the outer membrane of the bacterial cell 
wall. Lipopolysaccharide is a complex molecule divided into 
hydrophobic and hydrophilic regions. Lipid A is a hydrophobic 
glycolipid, the backbone of which consists of a glucosamine 
dissaccharide. Six saturated fatty acids are attached to the 
glucosamine backbone; the tails of the fatty acids are embedded in the 
outer membrane. Lipid A is responsible for many of the effects of 
LPS: endotoxicity, pyrogen production, vascular changes, macrophage 
and complement activation, etc. (Stryer 1981, Westphal et al. 1981). 
The other two components, the R core and the 0 side chains, are 
hydrophilic polysaccharides. The R core, or core oligosaccharide, is 
cha~acterized by 2 keto-3-deoxyoctonate (KDO) and heptulose sugars. 
The 0 side chains have repeating units of oligosaccharides which, by 
the variability of types and number of sugars attached, determine the 
0 antigenic specificity used for grouping gram-negative bacteria into 
serotypes. The R core varies very little between bacterial species, 
and lipid A is quite consistent for most genera. Studies of LPS have 
suggested that there is crosslinking of LPS monomer units by divalent 
cations such as ca+2 and Mg+2, possibly at the o side chains (Stryer 
1981, Westphal et al. 1981) or at pyrophosphate bridges on KDO units 
(Nikaido and Nakoe 1979), and that the structure and attachment of LPS 
is dependent on these divalent cations. 
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Bacteria that have complete LPS components are referred to as 
wild-type or smooth (S) strains. Strains that have oligosaccharide 
deletions in the O side chains and/or the R core are called rough (R) 
mutants. The S and R designations were derived from distinct 
differences in colony appearances of these bacterial types. Rough 
mutations occur when polysaccharide biosynthesis is blocked at one or 
more stages, producing shorter polysaccharide chaips. Wardlaw (1963) 
compared the cell-wall composition of smooth and rough strains of ~ 
coli and found that the major difference in composition between the 
two types was the amount of LPS; smooth strains had a higher 
percentage than rough strains of LPS. The transition from smooth to 
rough occurs by successive deletions of sugar residues. Deep rough 
mutants have only lipid A and three molecules of KDO. 
Another characteristic of the transition from smooth to rough is 
an increase in susceptibility to antibody and complement. Many 
strains of bacteria are readily killed by antibody and complement. 
Rough strains are generally more sensitive than smooth strains to 
killing, and many smooth strains are totally resistant. The 
polysaccharide side chains of S strains can cover and block antibody 
and complement receptors, inhibiting lysis by antibody and complement. 
Rough strains have shorter side chains than smooth strains, and 
antibody and complement have easier access to the cell wall. 
Smooth bacteria that are resistant to antibody-complement lysis 
can be made susceptible by exposure to substances that remove some of 
the LPS from the cell wall. Voss (1967) demonstrated that gram-
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negative bacteria resistant to killing in physiological saline would 
become more sensitive to killing when treated in tris(hydroxymethyl) 
aminomethane (Tris) buffer. He also observed that ethylene 
diaminetetraacetic acid (EDTA) also would render resistant strains 
more susceptible to killing. When the bacteria were exposed to both 
Tris and EDTA, Tris enhanced the bactericidal effect of serum and 
EDTI\.. The Tris buffer contains organic cations and is a mild chelator 
of inorganic divalent cations. The action of EDTA is to chelate 
inorganic divalent cations, such as ca+2 and Mg+2. When bacteria were 
exposed to both agents simultaneously, resistant bacteria became 
sensitive to killing by serum due to the removal of LPS from the cell 
wall (Voss 1967, Hedstrom et al. 1981, Reynolds and Pruul 197la). 
Reynolds and Pruul (197la,b) postulated that EDTI\. removed the 
divalent cations that crosslinked the phosphate groups on the LPS 
monomer units. The univalent cations, supplied by Tris, replaced the 
divalent cations and were unable to form crosslinkages. The 
substitution by univalent cations altered the LPS structure and caused 
the release of LPS. The concentration of Tris and EDTA required for 
removal of LPS did not affect viability of the bacteria, but high 
concentrations of EDTA, variations in pH (Hedstrom et al. 1981) and 
the duration of exposure to Tris and EDTA (Griffith and Kramer 1982) 
did-affect the action of the two agents so that they were 
bactericidal. 
Lipopolysaccharide prevents binding of antibody to specific 
antigens and complement to cell receptors or to bound antibody. The 
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treatment of bacteria with Tris and EDTA caused the release of LPS 
from the cell wall which allowed antibody to reach the cell wall and 
bind to its specific antigen. Complement is activated by antigen-
antibody complexes. The exact mechanism of complement recognition of 
bound antibody is unknown, but when the antibody is bound to the 
antigen, a conformational change in the structure of the antibody 
occurs which reveals the Clq receptor on the Fe portion of the 
antibody (Vogt 1974, Osler 1976). The component Cl is then fixed and 
activated to initiate the classical complement pathway. 
For many years, bacteria were thought to activate only the 
classical pathway. But complement is activated by bacteria in 
antibody-free serum (Wardlaw 1962, Muschel et al. 1964, Gerwurz et al. 
1968). Lipopolysaccharide activates complement by three mechanisms: 
antibody-dependent and -independent classical pathways and the 
alternate pathway. Evidence for alternate pathway activation by LPS 
was given in studies using agammaglob,,linemic serum, precolostral 
serum and C4-deficient serum (Sterzl et al. 1964, Muschel et al. 1964, 
Fine 1981). The levels of the late components, CS-9, were reduced 
after incubation with LPS, but the levels of the early C components 
were relatively unchanged (Gerwurz et al. 1968). It was reported that 
complement is bactericidal without antibody. Schreiber et al. 1979 
demonstrated that a mixture of purified alternate pathway components 
killed E. coli Kl2. Sterzl et al. (1964) found that precolostral 
piglet serum was bactericidal for gram-negative bacteria, and that the 
sensitivity to piglet complement increased with the degree of cell 
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wall roughness. But the results from other studies have reported that 
Cl was involved, and that the classical pathway was activated, 
possibly through the involvement of antibody. Fine (1974) coated LPS 
onto sheep erythrocytes (E-LPS). He found that LPS activated only the 
classical pathway, and a factor was required which was probably 
antibody to LPS. Lipopolysaccharide, but not E-LPS, activated the 
alternate pathway. Fine (1974) postulated that association with the 
erythrocyte membrane may have interfered with the ability of LPS to 
activate the alternate pathway. 
Lipopolysaccharide can bind Cl and activate the classical pathway 
independently of antibody (Fine 1974, Morrison and Kline 1977). Loos 
et al. (1974) determined that lipid A was the component which --
interacted with Clq, but the polysaccharide components could affect 
the interaction. A later study by Loos et al. (1978) confirmed these 
results and demonstrated that activated Cl also bound to LPS and was 
capable of binding C4. The binding of Cl by lipid A, with the 
subsequent cleavage and activation of the other components, was 
bactericidal for serum-sensitive bacteria (Betz and Isliker 1981). 
Lipopolysaccharide can activate complement by both pathways, but 
investigators have shown that activation of either pathway requires 
different LPS components. Bjornson and Bjornson (1977) tested three 
strains of Salmonella minnesota for their ability to activate 
complement. The smooth strain activated the alternate pathway. The 
Rb mutant, which lacked 0 side chains, activated the alternate pathway 
to a lesser extent. The deep rough mutant did not activate the 
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alternate pathway, but did activate the classical pathway. These 
results confirmed the findings of Loos et al. (1978) by demonstrating 
that the polysaccharide components of LPS activated the alternate 
pathway and lipid A interacted with Cl to initiate the classical 
pathway. Morrison and Kline (1977) observed that the length of the 
polysaccharide and the carbohydrate content also affected the 
activation of the alternate pathway. 
Therefore, it was demonstrated that LPS activated both complement 
pathways independently of antibody. But does complement activation 
lead to lysis and become bactericidal? Complement was effective in 
killing serum-sensitive bacteria, and sometimes serum-resistant 
bacteria when high enough concentrations of complement were used 
(Sterzl et al. 1964, Leist-Walsh and Bjornson 1979, Betz and Isliker 
1981). Schreiber et al. (1979) also demonstrated that C was 
bactericidal by the alternate pathway. Eleven proteins involved in 
the alternate pathway were isolated and purified. The isolated 
protein mixture and C4-deficient serum were each incubated with ~ 
coli Kl2. The isolated protein mixture, which was free of antibody, 
killed E. coli Kl2 to the same extent as the C4-deficient serum. 
Seventy-two field strains of Salmonella cholerae-suis var 
kunzendorf were tested by Griffith and Kramer (1982) for sensitivity 
to porcine antibody and complement. The bacteria were pretreated in 
Tris and EDTA (Tris-EDTA) and in saline, and were incubated with 
antibody and complement (A~). Treatment with Tris-EDTA enhanced 
killing by Ab-C as compared to saline pretreatment. The seventy-two 
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strains varied widely in sensitivity to killing. Some strains were 
identified as susceptible and other strains as resistant. In the 
present study, selected strains of§,:._ cholerae-suis obtained from 
Griffith and Kramer (1982) were tested for sensitivity to antibody-
independent complement killing. The assay used in the present study 
was a modification of the assay previously described (Griffith and 
Kramer 1982). The bacteria were pretreated in Tris-EDTA and in saline 
and then were incubated with Ab--C and with complement alone (C). 
Killing by Ab--C and by C and the effect of pretreatment with Tris-EDTA 
were compared. Six animal species were used as sources of C: bovine, 
equine, porcine, human, mouse, and guinea pig. These complements were 
tested to determine if the complement from each species was 
bactericidal, and if sensitivity of ~ cholerae-suis to complement 
varied with the species of complement used. 
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MATERIALS AND METHODS 
Bacteria 
Six strains of Salmonella cholerae-suis var kunzendorf (SC) were 
obtained from the seventy-two strains previously tested by Griffith 
and Kramer (1982). The six strains were selected on the basis of 
their responses to killing by porcine antibody and complement. 
Salmonella cholerae-suis var kunzendorf strains 9 (SC:9), 33 (SC:33), 
and 38 (SC:38) exhibited a high degree of sensitivity to killing (>85% 
killed). Salmonella cholerae-suis var kunzendorf strains 2 (SC2), 5 
(SC5), and 10 (SC10) were partially sensitive to killing (10-85% 
killed). Two strains of Escherichia coli K88 and K99 (EC K88, EC K99) 
obtained from H. W. Moon, National Animal Disease Center, Ames, Iowa, 
were laboratory-adapted strains. All strains were streaked once onto 
trypticase soy agar plates from the original agar slants, and were 
frozen in egg yolk at -70 C. 
Each strain was inoculated from the frozen egg yolk onto 
trypticase soy agar plates. Smooth colonies were transferred to 
nutrient broth (NB) and incubated eighteen hours at 37 c. The strains 
were standardized with NB to an absorbance of 0.20 O.D. at 550 nm. 
The strains were then diluted to 10-3 in nutrient broth. The bacteria 
were pretreated in 0.1 M Tris containing 100 ug/L ethylene 
.diaminetetraacetic acid (Tris-EDTA) or in sali.ne for 10 minutes by 
adding 1 ml 10-3 bacterial dilution to 9 ml Tris-EDTA or saline. 
After incubation, the bacteria were diluted directly to 10-6 in NB. 
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Antibody 
Porcine S. cholerae-suis antibody was prepared in gilts and used 
at a final dilution of 1:8000 in nutrient broth as previously 
described (Griffith and Kramer 1982). Porcine anti-E. coli K88 and 
K99 antisera were prepared in pigs by repeated injection of formalized 
bacteria. The titer was similar to that of the porcine anti-
Salmonella antibody and was used at a final dilution of 1:8000 in 
nutrient broth. The 1:8000 dilution of each porcine antibody (Ab) was 
nonagglutinating. The antisera were heat-inactivated at 56 C for 30 
minutes. 
Complement 
Bovine, equine, and porcine complements were obtained from a pool 
of sera from a minimum of three animals of each species. The domestic 
animals were bled by venipuncture, and the blood was allowed to clot 
for four hours at room temperature. Human C came from a pool of sera 
from a minimum of three volunteers. The sera were removed and kept 
frozen at -70 C. Guinea pig C and mouse C were obtained from Pel 
Freeze Co., Rodgers, Arkansas. Aliquots of each species complements 
were heated at 56 C for 30 minutes to inactivate the complement and 
were used as C controls in the assay. Complement (C) and heat-
inactivated C were absorbed three times at 4 C with lx1012 bacteria 
heat-killed (60 C for 1 hour) before the assay to remove natural 
antibody. Complement and heat-inactivated complement were used at 
final dilutions of 1:30 in NB. 
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Nutrient Broth 
Nutrient broth was used as a growth medium for bacteria and as a 
diluent for the assays. Nutrient broth was prepared by adding 5.0 
grams NaCl, 5.0 grams peptone, and 2.5 grams beef extract to one liter 
of water. The pH was adjusted to 7.2. 
Bactericidal Assay 
The assay consisted of adding 0.25 ml of the 10-6 dilution, 
containing approximately lx104 bacteria/ml pretreated in saline or in 
Tris-EDTA, to 0.25 ml each of porcine Ab (1:8000) + C (1:30), or C 
(1:30) +NB to give 0.75 ml total volume. The 1:8000 dilution of 
porcine Ab was nonagglutinating. The bacteria were also added to 
heat-inactivated c + NB and to NB as controls. After 5 hours 
incubation at 37 C, 10 ul samples were plated in triplicate onto 
Tergitol-7 TIC agar plates. Each assay was performed three times. 
Killing .was determined by the formula 
(100 - CFU) 100 = % killed 
CFU control 
Susceptibility was categorized into three groups. 
>85% killed = susceptible 
10-85% killed = partially susceptible 
<10% killed = resistant 
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RESULTS 
The results presented in Table 1 demonstrated how each strain was 
affected by Ab-C after pretreatment with Tris-EDTA. The objective was 
to determine if the strains varied in susceptibility to killing with 
each complement used. Every complement except mouse and guinea pig 
complement was effective against SC33 and EC K99. Results obtained by 
using SC9 were inconsistent; SC9 was susceptible to bovine, equine, 
and human C, but was resistant to the other complements. Strains SC2, 
scs, and SC10 varied very little in susceptibility to Ab-<:: killing. 
Equine, porcine, and human complements were highly bactericidal for 
SC38, but bovine, mouse, and guinea pig complements were only 
partially effective. E.coli strain-K88 was sensitive to bovine and 
equine C in the presence of Ab. 
The results presented in Table 2 indicated that C alone will kill 
strains pretreated with Tris-EDTA. Every C except mouse C was 
bactericidal for EC K99. Strain EC K99 was not susceptible to Ab and 
guinea pig C, but it was susceptible to guinea pig C alone. The 
presence of Ab may have affected activation of guinea pig C by the 
strain. Strains SC33 and SC 9 were susceptible to every C, with the 
exceptions of mouse and guinea pig complements. Bovine, equine, and 
human complements were effective for four of the eight strains. Mouse 
C was ineffective for all of the strains. 
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Table 1 Susceptibility of ~ cholerae-suis and .!:'.!._ coli strains 
pretreated with Tris-EDTA to killing by porcine Ab and C 
Source of Complement 
Bovine Equine Porcine Human Mouse Guinea pig 
s. cholerae-suis 
33 >85a >85 >85 >85 Hl-85 10-85 
9 >85 >85 <10 >85 <10 10-85 
2 <10 10-85 10-85 <10 <10 <10 
5 10-85 10-85 10-85 <10 <10 >85 
10 10-85 10-85 10-85 <10 <10 10-85 
38 10-85 >85 >85 >85 10-85 10-85 
E.coli 
K88 >85 >85 10-85 10-85 10-85 <10 
K99 >85 >85 >85 >85 <10 <10 
~ercent bacteria killed by Ab-C. 
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Table 2 Susceptibility of ~ cholerae-suis and ~coli strains 
pretreated with Tris-EDTA to killing by C alone 
Source of Complement 
Bovine Equine Porcine Human Mouse Guinea pig 
s. cholerae-suis 
33 >85a >85 >85 >85 Hl-85 10-85 
9 >85 >85 <10 >85 10-85 >85 
2 10-85 10-85 10-85 10-85 <10 <10 
5 10-85 10-85 10-85 10-85 10-85 >85 
10 10-85 10-85 10-85 10-85 <10 <10 
38 >85 10-85 10-85 >85 <10 Hl-85 
E. coli ---
K88 10-85 >85 10-85 10-85 <10 10-85 
K99 >85 >85 >85 >85 <10 >85 
~ercent bacteria killed by C. 
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The effects of C and Ab on bacteria pretreated with saline were 
presented in Table 3. Bovine, equine, porcine, and human complements 
were very effective in the presence of antibody in killing SC9, SC33, 
and EC K99. Guinea pig C also killed EC K99. None of the complements 
were effective against SC2, SCS, and SC10. Equine and human C were 
the most effective bactericidal complements, and again, mouse C was 
ineffective against all strains. 
Some strains pretreated with saline were susceptible to killing by 
C alone (Table 4). Bovine~ equine, porcine, and human complements 
were bactericidal for SC33 and EC K99. Equine and human C killed SC9; 
bovine, porcine, mouse, and guinea pig complements had little effect. 
Most of the complements, with the exception that guinea pig C killed 
SCS, were ineffective toward SC2, SCS, SC10. Again, mouse C had no 
killing effect on the bacteria. 
The results presented in Table 5 indicated that killing by C alone 
approximated killing by Ab-<:, whether strains were pretreated with 
Tris-EDTA or with saline. Every C, with the exception of mouse C, was 
effective for a minimum of one bacterial strain. The results 
indicated that C from these species was bactericidal in the presence 
or absence of antibody. All strains were resistant to killing by 
mouse complement. 
No single complement was bactericidal for every strain. Equine C 
was the most effective C, followed by bovine, porcine, and human 
complements. Mouse and guinea pig complements were relatively 
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Table 3 Susceptibility of ~ cholerae-suis and~ coli strains 
pretreated with saline to killing by porcine Ab and C 
Source of Complement 
Bovine Equine Porcine Human Mouse Guinea pig 
s. cholerae-suis 
33 >85a >85 >85 >85 10-85 10-85 
9 >85 >85 >85 >85 <10 <10' 
2 <10 10-85 <10 <10 <10 <10' 
5 10-85 Hl-85 <10 <10 <10 <10 
10 10-85 10-85 <10 <10 <10 <10 
38 10-85 10-85 10-85 >85 <10 <10 
E. coli ---
K88 10-85 >85 <10 <10 10-85 <10 
K99 >85 >85 >85 >85 <10 >85 
aPercent bacteria killed by Ab-C. 
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Table 4 Susceptibility of ~ cholerae-suis and ~coli strains 
pretreated with saline to complement alone 
Source of Complement 
Bovine Equine Porcine Human Mouse Guinea pig 
s. cholerae-suis 
33 >s5a >S5 >SS >SS lfiJ-S5 10-S5 
9 <10 >SS <10 >S5 <10 10-SS 
2 <10 10-S5 <10 <10 <10 <10 
5 10-S5 10-S5 <HI <10 <10 >S5 
10 10-SS 10-S5 <10 <10 <10 <10 
3S 10-SS 10-S5 10-S5 >SS <10 <10 
E. coli ---
KSS 10-S5 10-SS 10-S5 <10 10-SS <10 
K99 >S5 >SS >S5 >SS <10 <10 
aPercent bacteria killed by complement. 
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Table 5 Sunnnary of susceptibility of strains to species complements 
with and without Ab 
Bacterial Source of Complement 
pretreatment Bovine Equine Porcine Human Mouse Guinea pig 
Tris-ED'rn. 
Ab-<: 4/8a 5/8 3/8 3/8 0/8 1/8 
c 4/8 4/8 2/8 4/8 0/8 3/8 
Saline 
Ab-<: 3/8 4/8 3/8 4/8 0/8 1/8 
c 2/8 3/8 2/8 4/8 0/8 1/8 
~umber of strains killed >85% / total number of strains. 
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ineffective; the strains remained resistant or partially susceptible 
(with the exception of SC5 to guinea pig C). 
The effects of Tris-EDTA or saline pretreatment and the presence 
or absence of Ab were demonstrated in Table 6. A comparison was made 
between two variables (Ab-<: vs C, or saline ~ Tris-EDTA) when results 
were conflicting between the two variables, i.e., susceptible in the 
presence of one variable and resistant in the presence of the other 
variable. The partially susceptible category was not included in this 
comparison. The strains affected by the variables were presented in 
parentheses in Table 6. The comparison was made to determine if the 
differences in susceptibility were random, or were associated with 
certain strains, or were associated with the species of complement 
I 
used. Strain SC9 was associated with 50% of the differences in 
susceptibility, and it was the source of differences associated with 
bovine, equine, and porcine complements. Strains SC5 and EC K99 
differed in their susceptibility to guinea pig complement. Human, and 
mouse complements had no differences. Guinea pig C was the main 
source of overall variability; three strains changed susceptibility 
between variables when guinea pig complement was used. 
Eight strains were pretreated with Tris-EDTA.or with saline and 
tested for susceptibility to six species complements in the presence 
or absence of Ab (Table 7). The strains that were partially 
susceptible (10-85% killed) were not included. The results in Table 7 
demonstrated that pretreatment with Tris-EDTA enhanced C killing such 
that C killing approximated killing by Ab-<:. Fewer strains pretreated 
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Table 6 Summary of strains pretreated with Tris-EDTA or saline 
differing in susceptibility to Ab-C and C killing 
Source of Complement 
Bovine E~ine Porcine Human Mouse Guinea pig 
variable 
Tris-EDTA pretreated strains 
AB-C VS c 0a 0 0 0 0 l(K99)b 
Saline pretreated strains 
Ab-C vs C 1 (9) 0 1 (9) 0 0 2 (5,K99) 
Strains killed by Ab-C 
Tris-EDTA vs 0 0 1 (9) 0 0 2(5,K99) 
saline 
Strains killed by C 
Tris-EDTA vs 1 (9) 0 0 0 1 (K99) 
saline 
Saline or Tris-EDTA pretreated strains 
Ab-C vs C 0 1 (9) 0 0 2 ( 5, 9) 
Saline or Tris-EDTI\. pretreated strains 
C vs Ab-C 1 (9) 0 0 0 0 0 
~umber of strains. 
bidentification of strains. 
30 
Percentage of susceptibility differences caused by strains 
SC9 50% total differences (involving bovine and porcine C) 
SC5 21% 
EC K99 29% 
(involving guinea pig C only) 
(involving guinea pig C only) 
Table 7 The effect of pretreatment with Tris-EDTA on susceptibility 
of strains to Ab--C and to C 
Tris-EDTA Eretreatrnent Saline Eretreatrnent 
Ab--C Ab--C 
>85%a <10% >85% <10% 
>85% 14b 1 >85% 11 1 
c c 
<10% 0 6 <10% 3 18 
~ercent bacteria killed. 
~umber of strain combinations affected. 
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with saline were susceptible to Ab-<:: or to C, and the number of 
strains resistant to Ab-C or C was increased. 
The effects of Tris-EDTA and saline pretreatment on sensitivity to 
Ab-<:: were presented in Tables 1, 3, and 7. The effect of Tris-EDTA on 
susceptible strains was minimal: many of the susceptible strains 
.pretreated with Tris-EDTA were also killed by Ab-C when the strains 
were saline pretreated. But the effect of Tris-EDTA on resistant 
strains was more evident. Only six strains pretreated with Tris-EDTA 
remained resistant to Ab-<:: and to c. Eighteen strains after 
pretreatment with saline were resistant to Ab-C or to C. 
The eight strains were grouped into three categories of 
sensitivity to killing by Ab-<:: or by C. Sensitivity to killing varied 
by pretreatment and by species of complement used, although the 
strains could be identified overall as susceptible, partially 
susceptible or resistant. The susceptible strains, SC9, SC33, and EC 
K99, were the major strains of interest. 
Sensitivity to C alone was enhanced by Tris-EDTA for bovine, 
equine, and guinea pig complements. Killing by porcine, human, and 
mouse complements was not affected by pretreatment. The sensitivity 
of SC33 and EC K99 remained unchanged, regardless of pretreatment, but 
the sensitivity of SC9 pretreated with Tris-EDTA was increased. The 
effect of Tris-EDTA on resistant strains was even more dramatic. 
Eighteen strain combinations pretreated with saline were resistant to 
both Ab-C and C alone, however, only six strain combinations remained 
resistant after pretreatment with Tris-EDTA (Table 7). Pretreatment 
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with Tris-EDTA did not enhance susceptibility to Ab and mouse C or to 
mouse c alone. 
Equine C was the most bactericidal complement. The bactericidal 
activities of the species complements in decreasing order were: 
equine; human; bovine; porcine; guinea pig; and mouse. 
Sensitivity to equine C was affected by Ab and pretreatment with 
Tris-EDTA. No single strain was susceptible (>85% killed) to mouse 
complement, but mouse C was not totally devoid of bactericidal 
activity. Two strains, SC33 and EC K99, were partially susceptible 
(10-85%). Strain EC K99, which was highly sensitive to C, was 
completely resistant to mouse complement. Mouse and guinea pig 
complements were obtained commercially. When these two complements 
were tested in a hemolytic system (Part 2), mouse C was nonhemolytic 
for sensitized sheep and rabbit erythrocytes, but guinea pig C was 
highly hemolytic for sensitized sheep erythrocytes. It is possible 
that the mouse complement used for the present study was devoid of 
bactericidal complement activity. 
Heat-inactivated C was included as a C control. Only strain SC33 
was killed by heat-inactivated complement (Table 8). When pretreated 
with Tris-EDTA, SC33 was highly susceptible to heat-inactivated 
bovine, equine, and porcine complements, and partially to heat-
inactivated human and mouse complements. When SC33 was pretreated 
with saline, it was susceptible to heat-inactivated equine complement. 
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Table 8 Susceptibility of SC33 to C and heat-inactivated C 
Source of Complement 
Tris-EDTAa Bovine Equine Porcine Human Mouse Guinea Eig 
c 97b 98 96 97 68 76 
*CC 85 94 91 28 58 78 
Salinea 
c 96 99 85 92 49 64 
*C 82 97 77 16 51 47 
' 
I 
~acterial pretreatment. 
bPercent bacteria killed. 
~eat-inactivated C (56 C, 30 minutes). 
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DISCUSSION 
Lipopolysaccharide activates complement by both the classical and 
the alternate pathways. The traditional concept for the bactericidal 
activity of serum was that antibody bound to the bacterial cell wall 
and activated complement by the classical pathway. However, a number 
of investigators have observed that complement, without antibody, 
could be bactericidal against serum-sensitive gram-negative bacteria 
(Sterzl et al. 1964, Bjornson and Bjornson 1977, Loos et al. 1978, 
Schreiber et al. 1979). Betz and Isliker (1981) demonstrated that 
·antibody-free and Clq-free sera were bactericidal for ~coli, and the 
addition of Cl greatly increased killing. Lipopolysaccharide present 
in the cell wall was responsible for the antibody-independent 
activation of the classical complement pathway. The classical pathway 
was activated by lipid A, and the polysaccharide portion activated the 
alternate pathway (Loos et al. 1974, Fine 1974, Bjornson and Bjornson --
1977, Morrison and Kline 1977, Loos .et al. 1978, Pangburn 1983). 
Smooth strains of gram-negative bacteria are resistant to Ab-C 
because intact 0 side chains of LPS prevent access of Ab and/or C to 
the cell wall. Rough strains have oligosaccharide deletions and are 
serum-sensitive (Reynolds and Rowley 1969, Nikaido and Nakoe 1979, 
Westphal et al. 1981). Some of the LPS is removed when bacteria are 
exposed to Tris and EDTA, and many resistant strains become 
susceptible to antibody and C after removal of LPS (Reynolds and 
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Rowley 1969, Hedstrom et al. 1981, Wright and Levine 1981). 
Griffith and Kramer (1982) tested seventy-two field isolates of 
Salmonella cholerae-suis var kunzendorf for sensitivity to porcine 
antibody and complement. Their results indicated that Tris-EDTA 
enhanced sensitivity to Ab-C. Some strains were consistently 
susceptible or resistant to Ab-C. Three susceptible strains {SC9, 
SC33, SC38) and three resistant strains {SC2, SCS, SC10) of .§..:._ 
cholerae-suis and two strains (EC K88, EC K99) of ~ coli were used to 
determine if C alone could be bactericidal, and if susceptibility to C 
varied with the species of C used. The results presented here 
indicated that C was bactericidal and that sensitivity to C approached 
that of Ab-C after bacteria were exposed to Tris-EDTA. 
Pretreatment with Tris-EDTII. did not greatly enhance killing by Ab-
e of the eight strains tested. The results do not conflict with other 
studies because selection of the strains was not a random process. 
The S. cholerae-suis strains were selected for resistance or 
sensitivity to Ab-c. The two~ coli strains had not been previously 
tested; EC K99 was highly sensitive to killing regardless of 
pretreatment, and EC K88 was affected somewhat by Tris-EDTA. 
In many studies, serum-resistant bacteria were exposed to Tris-
EDTA to investigate the•bactericidal effects of C and Ab-c. Reynolds 
,and Rowley (1969) and Reynolds and Pruul (197la,b) tested smooth 
strains of Salmonella typhimurium with Tris-EDTA and found that 
removal of LPS uncovered C receptors, which may have been located in 
lipid A. The removal of LPS allowed sensitization of resistant 
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bacteria. In the present study, susceptibility to C was enhanced by 
Tris-EDTA, but some strains pretreated with saline were also killed by 
oomplement. The number of strains resistant to Ab-C and to C dropped 
from eighteen after pretreatment with saline to six when pretreated 
with Tris-EDTA (Table 7). Schreiber et al. (1979) reported that the 
mixture of purified alternate pathway components was bactericidal for 
E. coli Kl2. The components, however, were not bacteriolytic; 
lysozyme was required for bacteriolysis. 
Complements from six species were chosen to test the 
susceptibility of the eight selected bacterial strains. The species 
complements were compared with each other to determine the 
effectiveness of each C in the presence or absence of antibody against 
pretreated bacteria. Overall, equine C was the most bactericidal C, 
especially in the presence of antibody against bacteria pretreated 
with Tris-EDTA. Bactericidal complements in decreasing activity were 
equine, human, bovine, porcine, guinea pig, and mouse. 
Equine C has not been as well-studied as some of the other 
complements. It is commonly used as the complement source for bovine 
conglutination tests, because it is not a hemolytic c9mplement. Rice 
and coworkers did extensive work on testing hemolysis of sensitized 
sheep (Rice and Crowson 1950) and rabbit erythrocytes (Rice and 
Boulanger 1952) by different animal species complements. They 
reported that equine complement had very low titers of C2, C4, and C5. 
Barta and Barta (1978) also observed low or undetectable levels of C2, 
C4, and C5 in equine complement. In a different study by Barta and 
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Hubbert (1978), equine complement was bactericidal for ~coli. The 
presence of low levels of classical pathway components may have 
indicated that equine C killed bacteria through activation of the 
alternate pathway. It may also indicate that very low levels of early 
complement components, which are capable of initiating the 
conglutination reaction, are sufficient for initiation and activation 
of the classical pathway. 
Bovine complement has also been reported to contain low levels of 
C2 and C4 (Rice and Crowson 1950, Sterzl et al. 1964, Barta and Barta 
1978). Early work by Shrigley and Irwin (1937) demonstrated that 
bovine C was not herrolytic, however, it was very bactericidal for 
Brucella suis, either alone or in the presence of antisera. Bovine C 
was very effective for some of the Salrrvnella strains and for one 
strain of ~coli used in the present study. Sterzl et al. (1964) 
reported that calf serum was much rrore bactericidal for gram-negative 
bacteria than piglet serum. Low concentrations of piglet serum were 
effective for rough strains, but higher concentrations of sera were 
required to kill smooth strains. In the present study, bovine C.was 
also found to be more bactericidal than porcine complement. 
Human and guinea pig complements have been used extensively for 
herrolytic and bactericidal assays. Human C was a highly bactericidal 
complement. Only three strains, SCS, SC9, and EC K99, were 
susceptible to guinea pig complement. Shrigley and Irwin (1937) 
tested guinea pig C in tne presence and absence of antibody against 
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B. suis and found that it was not bactericidal, but it was fixed by 
the antigen-antibody complex. 
None of the eight strains tested were susceptible to mouse 
complement. A few strains were partially susceptible. The presence 
of antibody and Tris-EDTA pretreatment was not sufficient to render 
the bacteria susceptible, which indicated a lack of bactericidal 
activity of mouse complement. Brown (1943) and Muschel and Muto 
(1956) used human and.guinea pig sera deficient in specific complement 
components to determine if complement from normal mice was lackino an 
specific component (s). Their results indicated that C2 . .,~- no 
present. Muschel and Muto (1956) reported C2 and C3 to be absent. 
These deficiencies may account for the low bactericidal activity of 
rrouse complement. Both guinea pig C and mouse C were obtained from 
commercial sources. These two complements may have lost activity 
during processing and shipping, which may have accounted for the low 
bactericidal activities. 
The results from Table 6 indicated that differences in 
susceptibility occurred when two variables were compared. The 
differences were strain-related rather than random or species 
complement-related. A total of fourteen differences occurred. At the 
start of the present study, a larger number were expected because of 
enhancement of bactericidal C activity by Tris-EDTA pretreatment and 
antibody. Strain SC9, when pretreated with saline, was susceptible to 
bovine C in the presence of antibody, but it was resistant to bovine C 
in the absence of antibody (Tables 3 and 4). Strain SC9 was resistant 
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to Ab and porcine C when pretreated with Tris-EDTA and susceptible 
when pretreated with saline (Tables 1 and 3). The selective 
resistance of Tris-EDTA pretreated bacteria to Ab and porcine C was a 
characteristic of SC9. The irregular growth characteristics of SC9 
may account for the variability of results associated with this 
strain. Eight of the fourteen susceptibility differences occurred 
with guinea pig complement, and involved three strains. The majority 
of these were observed with resistance of SCS and EC K99 to Ab-C. 
The conclusions drawn from Table 6 were that SC9 differed in 
susceptibility to bovine and porcine complements. Differences in 
susceptibility to guinea pig C were influenced by pretreatment with 
Tris-EDTA and the presence of antibody. Equine and human complements, 
which were highly bactericidal, and mouse C, which was 
nonbactericidal, had no susceptibility differences. 
Heat-inactivated sera were only bactericidal for SC33. Each heat-
inactivated serum killed SC33 almost as well as its respective 
complement, with the exception of human complement. These results 
indicated that SC33 was highly susceptible to other serum 
component(s). The ability of SC33 to activate and consume complement 
was tested in Part 2. The results indicated that SC33 activated and 
consumed complement to the same level as the other three strains. 
Joiner et al. (1982 a,b) studied bacterial resistance to complement 
killing. Their results indicated that smooth bacteria consumed C3 and 
the terminal complement components, but that the CSb-9 complex formed 
on the cell surface was released without causing membrane damage. It 
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may be possible that other serum components such as lysozyme or 
transferrin are capable of killing or inhibiting growth of SC33. 
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CONCLUSIONS 
Complement alone killed some smooth strains of s. cholerae-suis var 
kunzendorf and E. coli to the same extent as antibody and 
complement. 
Pretreatment with Tris-EDTA enhanced killing by complement, but it was 
only slightly effective for enhancing antibody-complement 
killing. 
Equine complement was the most effective complement, followed by 
human, bovine, porcine, guinea pig and mouse complements. 
Mouse complement was not bactericidal as demonstrated by the lack of 
strains susceptible to it, but it may have lost complement 
activity during lyophilization, processing and shipping. 
Equine and human complements were consistently effective against 
susceptible strains. 
Strain SC33 was susceptible to heat-inactivated serum and to 
complement from each species, with the exception of human 
complement. This effect may have been caused by other 
bactericidal or bacteriostatic factors present in serum, such as 
transferrin or lysozyme. 
Differences in susceptibility and variations in test outcomes were 
traced to certain bacterial strains, and not to species 
complements or test methods. 
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PART 2 REDUCTION OF HEMOLYTIC COMPLEMENT LEVELS BY 
SALMONELLA CHOLERAE-SUIS AND ESCHERICHIA COLI 
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INTRODUCTION 
The results of various studies have shown that some bacteria are 
killed by complement independently of antibody, by activation of 
either the classical or the alternate pathway (Part 1 - Introduction). 
Lipopolysaccharide, a cell wall carbohydrate of gram-negative 
bacteria, activates the bactericidal activity of complement. Lipid A 
activates t'he classical pathway, and the polysaccharide portion of LPS 
activates the alternate pathway (Loos et al. 1978, 1974, Morrison and . --
Kline 1977). In Part 1 of the present study, the sensitivity of six 
strains of Salmonella cholerae-suis var kunzendorf and two strains of 
Escherichia coli were tested against complements obtained from six 
animal species. Equine C was the most bactericidal of the six 
complements, followed by human C, bovine C, porcine C, guinea pig C, 
and mouse C. Sensitivity to C was enhanced when bacteria were 
pretreated with Tris-EDTA to the extent that sensitivity to C was 
equal to sensitivity to antibody and complemen·t. 
Complement is often used with antibody in bactericidal and 
hemolytic studies. The study of complement is usually performed by 
using hemolytic assays. The standard hemolytic assay consists of 
sheep erythrocytes sensitized with rabbit antibody. A standard 
procedure commonly used or modified is the procedure described by 
Kabat and Mayer (Mayer 1971) for the complement fixation test. Guinea 
pig C is most often used in hemolytic assays and complement fixation 
tests. Sheep erythrocytes are sensitized with rabbit anti-sheep 
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antibody. Dilutions of pooled guinea pig C are added to the 
sensitized cells and incubated for one hour at 37 C. The degree of 
lysis is determined photometrically. 
Many investigators have attempted to titrate complement from 
different animal species by using the standard sheep erythrocyte-
rabbit antibody assay (Rice and Crowson 1950, Rice and Boulanger 1952, 
Grant 1976, Barta and Hubbert 1978). Equine, bovine, and sheep 
complements could not be titered with this assay and were considered 
to be nonhemolytic. Rice and Crowson (1950) performed an extensive 
study of complements from different animal species, using the standard 
system. In their study, components of species complements were 
interchanged, using the crude R reagents prepared from guinea pig 
complement. The R reagents were thought to contain three of the four 
known complement components, but they also contained additional 
components unknown at that time. Their results indicated that each of 
the three nonhemolytic complements had very low or undetectable levels 
of C2 and C4. In another study, Rice and Boulanger (1952) used rabbit 
erythrocytes sensitized with sheep anti-rabbit erythrocyte antibody 
and compared the two hemolytic systems using the same series of 
complements. Equine, bovine, and sheep complements were hemolytic for 
sensitized rabbit erythrocytes. Rice also indicated that these three 
complements had all four of the known C components. 
Barta and Barta (1978) also tested species complements for 
hemolytic activity. They used purified components from human and 
guinea pig complements instead of R reagents, and used radial 
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irnrnunodiffusion to detect components. Their results confirmed earlier 
reports (Rice and Crowson 1950, Rice and Boulanger 1952) that bovine 
and equine complements had low or undetectable levels of C2, C4, and 
in addition, C3. Barta and Barta (1978) and Leon and Norden (1959) 
suggested that the method of interchanging species C components to 
detect missing components was inappropriate because of incompatibility 
of some species complements. 
Rice and Crowson (1950) suggested that every vertebrate C would be 
hemolytic if tested in the appropriate system. Guinea pig and porcine 
complements are very hemolytic against sensitized sheep erythrocytes 
(Oykean and Barta 1980, Barta et al. 1970, Rice and Boulanger 1952). 
Bovine C is often tested in conglutination assays using sensitized 
sheep erythrocytes, and it is most hemolytic for sensitized guinea pig 
erythrocytes (Lachmann 1962, Triglia and Linscott 1980, Linscott and 
Triglia 1980). Rice and Boulanger (1952) reported that equine C was 
nonhemolytic for sensitized sheep erythrocytes, but it was hemolytic 
for sensitized rabbit erythrocytes. Leon and Norden (1959) reported 
that the early components of equine C reacted with sensitized sheep 
cells which were lysed after the addition of guinea pig C chelated 
with EDTA. Mouse C is reported to be nonhemolytic for sheep 
erythrocytes. Early studies by Brown (1943) and Muschel and Muto 
(1956), using R reagents, indicated that mouse C was lacking C2. But 
studies by van Dijk et al. (1980) indicated that mouse C was hemolytic 
for sensitized rabbit erythrocytes. 
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The hemolytic assay of sensitized erythrocytes is used to study 
the classical pathway. Many assays have been developed to study the 
alternate pathway. Since the alternate pathway does not involve the 
early C components, methods have been devised to block or inhibit 
these components. A number of substances activate the alternate 
pathway. Pillemer et al. (1954) used zyrnosan, a polysaccharide 
component of yeast cell walls, to absorb properdin from serum in his 
studies. Bacterial cell walls also activated the alternate pathway. 
Antibody aggregates, guinea pig and rabbit erythrocytes (Platt-Mills 
and Ishizaka 1974, Martin et al. 1976, Gadd and Reid 1981), cobra 
venom factor, and heat-killed cultured human kidney cells (Baker and 
Osofsky 1980) also activate the alternate pathway. 
Since the early C components Cl, C4 and C2 are pot required for 
the alternate pathway, sera that are naturally deficient in these 
components, such as C4-deficient guinea pig C and C2-deficient human 
C, or sera that have been processed to remove one of the components, 
are often used for C pathway studies. Absorption of serum with 
zyrnosan at 17 C to remove Factor B, and heating serum to 50 C for 30 
minutes are methods of blocking the alternate pathway. 
A simpler method of blocking the two C pathways is the selective 
use of chelators. Both the classical and the alternate pathways are 
dependent on divalent cations. The classical pathway requires ca+2 
for Clq to bind to its receptor and Mg+2 for binding C2. The 
alternate pathway requires only Mg+2 to stabilize the complex formed 
by alternate pathway factors. Ethylene diaminetetraacetic acid (EDTA) 
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chelates inorganic divalent cations, such as ca+2 and Mg+2, and blocks 
l::oth pathways. Ethylene glycol tetraacetic acid (EGTA) chelates ca+2; 
EGTA also chelates Mg+2 but to a much lesser extent than EDTA. 
Supplementing EGTA with Mg+2 overcomes this effect. The EGTA 
supplemented with Mg+2 is used to distinguish the alternate pathway by 
chelating ca+2 to block the classical pathway. The alternate pathway 
is not blocked because of the presence of Mg+2 (Fine 1977). The EGTA 
was used to study the alternate pathway of some complements from 
different species: human (Platt-Mills and Ishizaka 1974, Fine et al. 
1972, Fine 1977), guinea pig (Fine 1974), bovine (Triglia and Linscott 
1980, Linscott and Triglia 1980, 1981) and porcine (Traub. and Kleber 
1976). 
Fine et al. (1972) described a method in which EDTA and EGTA were 
used to study C activation by different substances. The· substances, 
sensitiz~d sheep erythrocytes, zymosan, and ~coli, were incubated 
with C and C chelated with EDTI'. or EGTA for one hour. After 
incubation, the substances were rerroved, and the chelators saturated 
by the addition of ca+2. The complements were titered to determine if 
the complement levels were reduced by the substances, and if any of 
the substances activated the alternate pathway. Their resulr~ 
indicated that the alternate pathway of human C was acti"aten by 
zymosan and by ~ coli • 
The results of earlier studies have indicated that the antibody-
independent bactericidal activity of complement can occur by either 
pathway. The method described by Fine et al. (1972) was used in+-'-·" 
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study to determine which pathway was activated by each bacterial 
strain, and if each species complement was activated by the same 
pathway. Fine·'s method was selected because earlier attempts to 
measure C activation by C3 conversion (Baker and Osofsky 1980) and by 
gel diffusion (Martin et al. 1976, Gerwurz et al. 1978) were 
unsuccessful. The four complements which were most bactericidal (Part 
1), equine, human, bovine, and porcine, were selected. Four strains 
of bacteria were chosen as test reagents: ~ cholerae-suis strains 9, 
33, and 38, and E. coli K99. Bovine C was chelated with different 
concentrations of EDTA and EGTA to determine if lysis of sheep 
erythrocytes by bovine C was caused by the alternate pathway or by 
incomplete chelation of ca+2. 
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MATERIALS AND METHODS 
Erythrocytes 
Sheep and rabbit erythrocytes were collected into Alsever's 
solution and aged for a minimum of four days. The erythrocytes were 
washed three times in Veronal buffered saline (VBS) and standardized 
to 2.8% by adjusting the cell suspension with VBS at an absorbance of 
540 nm. Fresh 2.8% erythrocyte suspensions were prepared prior to 
each assay. 
Antibody 
Rabbit anti-sheep erythrocyte antibody was obtained from Gibco 
Laboratories Co., St. Louis. Sheep anti-rabbit erythrocyte antibody 
was prepared by repeated injection i.v. of a 10% suspension of washed 
rabbit erythrocytes. Both antisera were heat-inactivated at 56 C for 
30 minutes. The rabbit antibody was titrated with sheep erythrocytes 
and guinea pig complement. Sheep antibody was titrated with rabbit 
erythrocytes and bovine complement. Both titrations were performed by 
the method described by Gustafson and Pearson (1981). The optimum 
antibody dilution of each antibody was 1:1500. Sensitized 
erythrocytes for the hemolytic assay were prepared by incubating equal 
volumes of a 2.8% suspension of washed erythrocytes and a 1:1500 
antibody dilution for 15 minutes at 37 C. 
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Diluent 
Veronal buffered saline was prepared as 5X VBS stock solution by 
adding 83 grams NaCl, 10.19 grams Na-5,5-diethyl barbituate, and 34.58 
ml 1 N HCl to 2 liters water. The stock solution was supplemented 
with 5 ml 1 M Mg+2 - 0.3 M ca+2 and stored at 4 c. Fresh VBS was 
prepared by dilution in 0.1% gelatin water before each assay. 
Color standards 
Hemoglobin was prepared by lysing 1 ml of a 2.8% suspension of 
erythrocytes with 7 ml water, then adding 2 ml of 5X VBS stock 
solution. Erythrocytes (2.8% suspension) were diluted 1 ml into 9 ml 
VBS and mixed with henoglobin in the manner presented below. The 
color standards were compared visually to determine the percent 
hernolysis after centrifugation. Fresh color standards were prepared 
prior to each assay. 
% hemolysis 
hemoglobin 
erythrocytes 
Color standard preparation 
0 10 20 30 
0 .1 .2 .3 
1 .9 .8 . 7 
40 50 60 70 
.4 .5 .6 .7 
.6 .5 .4 .3 
Che la tors 
80 
.8 
.2 
90 
.9 
.1 
100 
1 
0 
Solutions of EDTA and EGTI\.-Mg were prepared as described by Fine 
et al. (1972) and stored as 100 mM stock solutions. The EGTA-Mg stock 
solution and saline were supplemented with 10 mM Mg+2. The stock 
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solutions of the chelators and saline-Mg each were added (0.1 ml) to 
0.9 ml complement to yield c-saline-1 mM Mg, C-10 mM EDTA, and C-10 rrM 
EGTil.-1 mM Mg. 
Test Reagents 
Sensitized erythrocytes 
Cell suspensions were adjusted to 2x108 cells/ml with VBS as 
determined by Coulter counter. Sensitized erythrocytes (EA) were 
prepared by mixing 2xl08 washed erythrocytes with equal volumes of 
1:1500 antibody, and incubating for 15 minutes at 37 C. The cells 
were then washed three times in saline to remove excess antibody and 
VBS. Ten milliliters of sensitized erythrocytes were packed by 
centrifugation, and the cells were resuspended in 1 ml C to yield 
2xl09 cells/ml c. The EA were prepared prior to each assay. 
Zymosan 
Zymosan (Z) was homogenized and washed three times in saline, and 
kept frozen in aliquots of 2 mg/ml saline. Prior to each assay, the 
zymosan was thawed, packed by centrifugation, and resuspended in 1 ml 
complement to yield 2 mg Z/ml c. 
Bacteria 
S. cholerae-suis var kunzendorf strains 9 (SC9), 33 (SC33), 38 
(SC38), and~ coli strain K99 (EC K99) were streaked from frozen egg 
yolk onto tryptose soy agar. Smooth colonies were transferred to 
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tryptose soy broth, and incubated eighteen hours at 37 C. Viable 
bacteria were determined by counting bacterial colony-forming units 
(CFU) on Tergitol-7 with TIC agar plates: SC9 5 x10ll bacteria/ml, 
S::::33 4 x1012 bacteria/ml, SC38 4 x 1012 bacteria/ml, and EC K99 1 x 
1012 bacteria/ml. The bacteria were killed by boiling for 30 minutes, 
washed three times in saline, and frozen in 1 ml aliquots. One day 
prior to the assay, aliquots of each strain were thawed, washed in 
saline, and dried overnight. The cells were resuspended in 1 ml 
complement. 
Incubation Procedure 
Complement was thawed in an ice bath. Complement (0.9 ml) was 
incubated with the chelators (0.1 ml) and saline-Mg (0.1 ml) for 10 
minutes at room temperature. The test reagents each were resuspended 
in 1 ml of complement as described under Test Reagents, and incubated 
for one hour at 37 C with shaking. The test reagents were removed by 
centrifugation from the complement, and 0.1 ml of 100 mM ca+2 was 
added to each of the complements to saturate the EDTA or EGTA. 
Controls consisted of C, C-saline-Mg, C-EDTA, and C-EGTA-Mg without 
test reagents. Controls were incubated for one hour at 37 C with 
shaking. The controls were included to determine if complement was 
inactivated after incubation. 
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Complement Titration 
After the addition of ca+2, the complements and controls were 
diluted in VBS and refrigerated for 20 minutes. During C 
refrigeration, sensitized erythrocytes for the hemolytic assay were 
prepared. Each C dilution, sensitized erythrocytes, and VBS were 
added to duplicate sets of four tubes in the following manner. 
Tubes 
l 2 3 4 
VBS ml .6 • 55 .5 .4 
C dilution .2 .25 .3 .4 
sens. erythrocytes .2 .2 .2 .2 
The tubes were incubated for one hour in a 37 C water bath, then 
the cells were packed by centrifugation. The percent hemolysis in 
each tube was determined by comparison to hemoglobin color standards. 
CH50 Determination 
The C titration and CH50 determination were performed by the 
procedure previously described (Gustafson and Pearson 1981). The 
percent hernolysis was converted to y/100-y value (y=% hernolysis), 
which was plotted against C volume/tube on log paper. The C dilution 
that gave two points on either side of the midpoint of the log paper 
was used to determine CH50. A line was drawn from the midpoint of 
tubes l and 2 to the midpoint between tubes 3 and 4. The point at 
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which the line intersected with the 50% hemolysis value (y/100-y=l) 
determined the volume of that C dilution which would lyse 50% of the 
sensitized erthrocytes. The CH50 was determined by the formula 
C dilution = CH50/ ml undiluted C 
~1.c 
Bovine, porcine, and human C results were expressed as percent in 
reductions of CH50 values as compared to control CH50 values. Bovine, 
porcine, human, and equine complements were tested three times. 
Bovine complement was.incubated and titrated with rabbit erythrocytes 
and sheep antibody. Human and porcine complements were incubated and 
titrated with sheep erythrocytes and rabbit antibody. Mouse 
complement was assayed for hemolytic C activity to determine if C 
activity could be detected. Mouse complement was incubated and 
titrated with sheep and rabbit antibody and with rabbit erythrocytes 
and antibody. 
Chelation of Bovine Complement with EDTI\. and EGTI\. 
Aliquots of bovine C were chelated with 0.1 ml of 100, 200, and 
400 rnM EDTA and EGTA. The EGTA was supplemented with respective 
concentrations of 10, 20, and 40 rnM Mg+2. The chelated complements 
were incubated with rabbit EA. After removal of test reagents, 0.1 ml 
of 100rnM, 200 rnM, and 400 rnM ca+2 was added to the respective 
complements. The complements were titrated as previously described 
(Table 11). Bovine C was also chelated with 200, 400, and 600 rnM EGTA 
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supplemented with 20 mM Mg+2 or with their respective higher Mg+2 
concentrations to determine the effects of different EGTA and Mg+2 
concentrations on bovine C (Table 12). 
Conglutination Assay 
Conglutinin 
Bovine blood was obtained by venipuncture and allowed to clot at 
room temperature overnight. Nine ml of serum were chelated with 1 ml 
0.6 M EGTA supplemented with 0.06 M Mg+2, then incubated with 2 g 
zymosan/ml for one hour at 37 C. The zymosan was removed by 
centrifugation. The serum was dialyzed against VBS at 4 C for two 
days, then heat-inactivated at 56 C for 30 minutes, and was absorbed 
three times with washed sheep erythrocytes. The conglutinin had no 
hemolytic activity for rabbit erythrocytes. The optimal conglutinin 
dilution of 1:8 was selected by using a block conglutination test. 
Conglutination assay 
The determination of reduction of equine complement by the test 
reagents involved two steps. Aliquots of equine complement were used 
as C-saline-1 mM Mg+2 and C-10 mM EGTA-1 mM Mg+2, and incubated with 
sheep erythrocytes and zymosan as previously described. After the 
addition of ca+2, equine C and C-EGTA levels were measured by a 
conglutination assay. Equine C and C-EGTA were diluted in two-fold 
56 
serial dilutions; 0.25 ml of each C dilution was added to a 13 x 100 
tube. Sensitized sheep erythrocytes (0.25 ml) and VBS (0.25 ml) were 
added to each tube. The tubes were shaken vigorously. Conglutinin 
(0.25 ml of 1:8 dilution) was added to each tube to give a total 
volume of 1 ml/tube, and the tubes were again shaken. Sensitized 
erythrocytes were added to VBS, C and VBS, and conglutinin and VBS as 
nonconglutinating controls. The tubes were incubated 1 hour at 37 C, 
and refrigerated eighteen hours. 
The conglutination endpoints were read visually. The erythrocytes 
were counted on a Coulter counter after the visual endpoints were 
determined. Percent conglutination was determined by 
(100-count)l00/nonconglutinating control count. 
The percent reduction of equine C and C-EGTA was determined by 
comparing percent conglutination of reduced complement to controls not 
incubated with test reagents by the formula 
100-% conglutination/control % conglutination. 
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RESULTS 
Bovine C and C-EGTA-Mg CH50 units were both reduced to 
approximately equal levels by EA, Z (Table 9), and the bacterial 
strains (Table 10). None of the test reagents affected C-EDTA. The 
test reagent EA activated the alternate pathway of C-EGTA (Table 9). 
Since C-EDTA was not reduced by EA or z, there was no excess ca+2 
present in the C to account for the reduction of C-EG'.11\-Mg by EA. 
The bacterial strains and Z consumed porcine C and C-EGTA-Mg and 
reduced the CH50 titer to approximately equal levels, with the 
exception of SC38, which was not as effective in reducing the CH50 
level to the same extent as Z (Tables 9 and 10). The C-EDTA was not 
reduced by any of the incubation substances. The test reagent EA 
reduced the CH50 level of C, but did not reduce C-EGTA-Mg. 
Human complement CH50 units were reduced to equal levels by Z and 
the bacterial strains. The C-EDTA was not reduced by any of the test 
reagents. The C-EGTA~ was not reduced by EA. All four strains of 
bacteria activated the alternate pathway in each of the complements, 
equal or slightly below the level of reduction by z. The test reagent 
EA activated the alternate pathway of bovine C, as demonstrated with 
C-EGTA-Mg, but had no effect with porcine or human C-EGTA. Human and 
porcine complements were tested with sheep erythrocytes; bovine 
complement was tested against rabbit erythrocytes. The results may 
indicate that rabbit erythrocytes activated the alternate pathway, and 
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Table 9 Reduction of C levels by EA and Zymosan 
control titer 
c 
EA C-EDTA 
C-EGTI\ 
z 
c 
C-EDTA 
C-EGTA 
Bovine 
35 CH50 
63 
0 
69 
~50 reduction. 
Porcine 
207 
84 
0 
0 
64 
0 
70 
Human 
207 
100 
0 
0 
62 
0 
65 
59 
Table 10 Reduction of C levels by bacteria 
Bovine Porcine Human 
c 69 66 
SC9 C-EDTA 
C-EGTA 54 66 66 
c 56 68 66 
SC33 C-EDTA 
' 
C-EGTA 57 69 61 
c 56 51 63 
SC38 C-EDTA 
C-EGTA 50 52 56 
c 57 67 64 
ECK99 C-EDTA 
C-EGTA 59 65 56 
'1iercent CH50 reduction. 
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sheep erythrocytes activated the classical pathway. Porcine and human 
C-EGTA were not reduced by EA. 
Aliquots of bovine C were chelated with increased concentrations 
of EDTA, EGTA and Mg+2 to assure complete chelation of ca+2. 
Complement chelated with any concentration of EDTA was not affected by 
EA. However, EA depleted C-EGTA-Mg at each concentration of EGTA-Mg 
(Table 11). When 600 mM EGTA and different concentrations of Mg were 
tested against EA, similar results were observed (Table 12). The 
discrepancy of results between Tables 9 and 11 were caused by 
different dilutions of bovine complement. A 1:2 dilution of bovine C 
(Table 9) was reduced 78% by EA. Later results of the effect of EA on 
bovine C-EGTA indicated that, when bovine C was diluted to 1:3 in all 
tests, no subsequent hemolytic C activity was detected (Tables 11 and 
12). 
Equine C and C-EGTA were reduced to approximately equal levels by 
sheep erythrocytes in the conglutination assay (Table 13). Equine C 
was not reduced when incubated with zymosan, but it was reduced, when 
chelated with EGTA, by zymosan. It may be possible that equine C was 
reduced but not to the same extent as C-EGTA, and the C reduction was 
not detected by the conglutinin assay. A great deal of variability 
was observed with this test. Although actual numbers differed from 
test to test, the percent reduction were consistent. The results 
indicated that equine C was activated by the alternate pathway by both 
sheep erythrocytes and zymosan. Similar results were observed with 
bovine complement. 
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Table 11 Reduction of Bovine C-EDTA and C-EGTA-MG by EA 
Chelator Concentrations 
100 rnM 200 rnM 400 rnM 
EDTA 0 
EGTA 100 100 100 
~ercent CH50 reduction. 
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Table 12 The Effect of EA on Bovine C-EGTI'.-Mg 
.2 M EGTA-.02 M Mg 
EGTI'.-Mg Molarity 
.4 M EGTI'.-.02 M Mg 
100 
.6 M EGTA-.02 M Mg 
100 
.4 M EGTA-.04 M Mg .6 M EGTI'.-.06 M Mg 
100 100 
aPercent CH50 reduction. 
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Table 13 Reduction of Equine Complement Levels by Test Reagents 
Erythrocytes Zymosan 
c dilution c C-EGTA c C-EGTA 
1:32 64a 70 0b 50 
1:64 50 58 0 55 
1:128 28 nae 31 nd 
aPercent reduction of conglutinating complement levels. 
11<0 reduction at this dilution, erythrocytes were too 
conglutinated to count. 
~ot done. 
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Incubation with EA is the standard procedure to activate the 
classical pathway of complement. Zymosan activates the alternate 
pathway. The reductions of CH50 units by bacteria were compared to 
reductions by EA and zymosan to determine which pathway the bacteria 
activated, if each strain activated the same pathway, and if the same 
pathway was activated by the complement of each species. 
The alternate and classical pathways were blocked by chelation of 
ca+2 and Mg+2 by EDTA. The C-EDTA was not reduced by any of the 
incubation substances. The classical pathway was blocked in 
complement chelated with EGTA, but the alternate pathway could be 
activated. The hemolytic c levels of C-EDTA and C-EGTA-Mg were 
compared to C-saline-Mg to determine which C pathway was activated in 
the unchelated complement. 
There was some variation of reduction of C levels between the test 
reagents, but the comparison of C and C-EGTA-Mg levels after incubaton 
with each test reagent indicated that C and C-EGTA-Mg were reduced to 
equivalent levels by Zand the bacterial strains (Tables 9 and 10). 
Unchelated C activated either the classical or the alternate pathway. 
Each bacterial strain reduced CH50 values to the same extent as Z, 
indicating that all four strains activated the alternate pathway. The 
bacterial strains also activated the alternate pathway in each species 
complement tested (Table 10). 
Undiluted commercial and fresh mouse complements were incubated 
with and without sensitized sheep and rabbit erythrocytes, and then 
titrated with both sensitized erythrocytes to determine if mouse 
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complement had hemolytic activity. Bactericidal activity of mouse C 
was not detected (Part 1). No lysis of erythrocytes was observed 
after incubation, and no hemolytic activity by commercial or fresh 
mouse complements was observed. Lysis of rabbit erythrocytes (van 
Djik et al. 1980) and sheep erythrocytes (Berden et al. 1978) by mouse 
C has been reported. The mouse c used in the present study, however, 
was nonhemolytic. 
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DISCUSSION 
Fine et al. (1972) used EDTA and EGTA to stu?y activation of human 
and guinea pig complements by the alternate pathway. The EDTA blocked 
both classical and alternate C pathways by chelating ca+2 and Mg+2, 
while EGTA blocked only the classical pathway by the chelation of 
ca+2. · Studies with human (Fine et al. 1972, Fine 1977) and guinea pig 
complements (Fine 1974) indicated that E:.:._ coli activated the alternate 
pathway in normal complement and in complement chelated with EGTA. 
Other investigators have indicated that not all gram-negative 
bacteria activate the alternate pathway (Fine 1974, Traub and Kleber 
1976, Roberts and Philips 1981, 1983, Hoffman and Houle 1983). Some 
gram-positive bacteria, which lack LPS, also activate complement via 
the alternate pathway. Lipopolysaccharide activates complement by 
either the classical or the alternate pathway. In the present study, 
three strains of s. cholerae-suis var kunzendorf .and one strain of E. 
coli were tested for their ability to reduce complement levels by 
either pathway. Three of the strains, SC9, SC33 and EC K99 were 
susceptible to complement killing. One strain, SC38, was partially 
susceptible to complement. 
Activation of the alternate pathway was determined by two 
procedures. Zymosan is a known activator of the alternate pathway. 
Zymosan binds Factor B at 17 C and both Factor B and C3b at 37 C 
(Nicholson et al.· 1974). The complements in the present study were 
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not treated to rell'Ove anti-Z antibody, indicating that anti-Z 
antibodies may have been present to activate the classical pathway. 
Blockage of the classical pathway by EGTA prevented classical pathway 
activation. A comparison of C and C-EGTA CH50 levels after Z 
incubation indicated that Z activated only the alternate pathway. The 
reduction of bovine, porcine and human C and C-EGTA by bacteria were 
comparatively equal; C-EGTA reduction was sometimes slightly greater 
with certain strains. The four bacterial strains reduced C and C-EGTA 
to the same extent as zyll'Osan. The reduction of C levels by EA was 
greater than reduction by Z or by bacteria. The results indicated 
that the three~ cholerae-suis strains 9, 33, and 38 and ~coli K99 
activated the alternate pathway in bovine, porcine, and human 
complements. The results concurred with reports of gram-negative 
bacteria activating the alternate pathway. 
Human C was completely depleted by EA (Table 9). Human complement 
chelated with EDTA and EGTA was not affected by EA. These results 
agreed with results obtained previously (Fine et al. 1972). However, 
zyrnosan and the bacterial strains only reduced complement levels by 
50-60%. Fine et al. (1972) reported that human c was completely 
depleted by the test reagents. The concentration of zyrnosan in the 
present study was the same concentration used by Fine et al. (1972), 
and the bacterial concentrations were 103 greater than concentrations 
used by Fine. Their results indicated that Z and E. coli also 
completely depleted human complement. The discrepancy in results 
between Fine and this study may be due to C dilution by the test 
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reagents. Fine's report did not specify the concentration of the 
test reagents and of the complements. In the present study, test 
reagents were packed by centrifugation, resuspended in complement and 
removed by centrifugation with very little dilution of complement, 
which enabled hemolysis to be detected. 
Equine C was incubated with sensitized sheep and rabbit 
erythrocytes to determine which erythrocyte system would be optimal. 
The results from earlier studies (Rice and Crowson 1950, Rice and 
Boulanger 1952) indicated that equine C was nonhemolytic for 
sensitized sheep erythrocytes, but it was hemolytic for sensitized 
rabbit erythrocytes. Barta and Hubbert (1978) also reported that 
equine complement was hemolytic for rabbit erythrocytes. Leon and 
Norden (1959) reported that the early components of equine C reacted 
with sheep erythrocytes. Undiluted equine C was only slightly 
hemolytic (<50% hemolysis) for sensitized rabbit erythrocytes, and it 
was nonhemolytic for sheep erythrocytes. Another method was used in 
the present study to determine equine C reduction by test reagents. 
Equine C is routinely used as the source of complement in bovine 
conglutination assays. The conglutination test was modified to 
measure reduction of equine C levels by standardizing conglutinin and 
sensitized sheep erythrocytes. Activation of the alternate pathway of 
equine C by EA was demonstrated by the reduction of C-EGTA levels. 
Sensitized sheep erythrocytes, which activated the alternate pathway 
in bovine C, produced similar results with equine c. 
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Mouse C was nonbactericidal for each of the bacterial strains 
tested. Attempts were made to determine C activity in mouse C by 
hemolysis of sensitized erythrocytes. Commercial and fresh mouse C 
,were incubated with sensitized sheep and rabbit erythrocytes. No 
hemolysis was observed with either complement or erythrocytes. 
Muschel and Muto (1956) and Brown (1943) also reported that mouse C 
was nonhemolytic and indicated that mouse C lacked C2. But van Dijk 
et al. (1980) reported that mouse C was hemolytic for sensitized 
rabbit erythrocytes by the classical pathway. They reported that 
mouse hemolytic C levels exceeded even guinea pig C levels. They also 
indicated that mouse c was hemolytic via the alternate pathway for 
higher concentrations of complement. Berden et al. (1978) reported 
hemolysis of sensitized sheep erythrocytes by mouse C using Slcr-
labelled erythrocytes. Both of these procedures were more sensitive 
in detecting hemolysis than the procedure used in the present study. 
The greater test sensitivity may have accounted for the differences in 
results. 
Incubation with sensitized erythrocytes has been the traditional 
method of studying the classical pathway. Some studies have indicated 
that unsensitized erythrocytes of some species can activate the 
alternate pathway of some species complements, and that antibody may 
have a role in activation of the alternate pathway. Platts-Mills and 
Ishizaka (1974) reported hemolysis of rabbit erythrocytes by human C 
via the alternate pathway. Human C was chelated with EGTA and 
incubated with washed rabbit erythrocytes. Hemolysis was determined 
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photometrically. Their results indicated that EGTA blocked Cl 
binding, but not C2 and C4. Their results also indicated that human C 
was hemolytic via the alternate pathway for rabbit erythrocytes, but 
not for sheep erythrocytes. The results of the present study and the 
study by Fine et al. (1972) have agreed with the results obtained by 
Platts-Mills and Ishizaka in indicating that human C was not hemolytic 
for sheep erythrocytes when chelated with EGTA. 
Renshaw and Gilmore (1980) studied the alternate pathway in 
porcine complement using 0.10 M EDTA and EGTA, and unsensitized 
species erythrocytes. Their results indicated that guinea pig 
erythrocytes were optimal for porcine complement. Rabbit erythrocytes 
were lysed to some extent. Goat, sheep, cat, dog, and bovine 
erythrocytes were insensitive to lysis by porcine complement. Oykean 
and Barta (1980) tested several species of erythrocytes to determine 
the optimal conditions required for titering porcine complement. 
Their results indicated that sheep and bovine erythrocytes were 
optimal for porcine complement. Rice and Crowson (1950) also reported 
that porcine C to be highly hemolytic for sheep erythrocytes. 
Pang and Aston (1977) reported that bovine serum was hemolytic for 
human erythrocytes. In their study, bovine sera, either chelated with 
EGTA or depleted of Cl, were hemolytic for human erythrocytes. But 
sera, absorbed with Z at 17 C or heat-inactivated at 50 C to remove 
Factor B, were not hemolytic for human erythrocytes. In the present 
study, bovine C and C-EGTA were hemolytic for sensitized rabbit 
erythrocytes. Rice and Boulanger (1952) reported that bovine C was 
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hemolytic for sensitized rabbit erythrocytes, but it was not hemolytic 
for sheep erythrocytes. 
Linscott and Triglia (1980) and Triglia and Linscott (1980) 
studied C components of adult and fetal bovine sera. They indicated 
that the concentrations of EDTA and EGTA commonly used (10mM/ml C) 
were not sufficient to block all Cl activation. Their results 
indicated that a minimum of 40 mM EDTA/ml C was required to completely 
block Cl from binding to the erythrocyte. In the present study, 
bovine C was chelated with EDTA to yield 10 Mm, 20 mM, and 40 mM of 
each chelator/ml c, and then incubated with sensitized rabbit 
erythrocytes. In addition, EGTA was also included as a separate test. 
Complete hemolysis occurred with each concentration of EGTA, and no 
hemolysis was observed with any concentration of EDTA. Brock et al. 
(1975) also reported that 10 mM EGTA/ml C was sufficient to block the 
classical pathway of bovine complement. If 10 mM EDTA/ml C had been 
insufficient to block Cl, some lysis would have been observed. The 
method to detect and determine hemolysis used in the present study was 
not as sensitive as the method used by Linscott and Triglia (1980). 
However, their method involved guinea pig C components and isolated 
bovine C components. They reported that EACl was readily lysed by 
guinea pig C in 0.10 M EDTA.· If EA had been lysed by bovine C in 0.10 
M EDTA, hemolysis would have been detected by the method described in 
the present study. 
It is possible that other factors may have contributed to 
activation of the alternate pathway by EA. Antibody aggregates are 
• 
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known activators of the alternate pathway. Polhill et al. (1978) 
studied the effect of antibody on the alternate pathway. Their 
results indicated that fixation of C3 was slower by the alternate 
pathway than by the classical pathway, and that antibody enhanced 
fixation. Other studies have reported that the F(ab'l 2 region of 
antibody, not rabbit eryhtrocytes, was responsible for hemolysis by 
activation of human c by the alternate pathway {Gadd and Reid 1981, 
Schenkin and Ruddy 1981). Excessive Mg+2 also has been demonstrated 
to activate C by the alternate pathway. A report by Fine (1977) 
indicated that EGTA-Mg was preferred over EGTA. The EGTA-Mg itself 
could activate the alternate pathway, but excess test reagent (2 rrg 
zymosan) and prolonged incubation time (1 hour) would overcome this 
effect. In the present study, both these conditions were met. There 
is a possibility that the excessive Mg+2 levels used to study the 
effect of different concentrations of EGTA on bovine complement may 
have affected the results. 
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CONCLUSIONS 
Residual nonchelated C and C-EGTA-Mg levels were comparatively equal 
after incubation with z and each of four bacterial strains. 
The alternate C pathway was activated in bovine, equine, porcine and 
human complements by SC9, SC33, SC38 and EC K99. 
Bovine C and C-EGTA-Mg levels were reduced to approximately equal 
levels by EA, indicating that EA activated the alternate pathway 
of this complement. The concentration of 0.010 M EDTA/ml C was 
sufficient to block Cl from binding to the erythrocytes and 
initiating the classical pathway. The concentration of 0.01 M 
EGTI\/ml C blocked the classical pathway, but not the alternate 
pathway of bovine complement. 
Equine complement was nonhemolytic for sheep and rabbit erythrocytes. 
When equine complement was tested in a conglutination assay, c-
EGTA-Mg levels were reduced by Z and EA. Reduction of equine C 
by Z was not observed. More study of equine complement is 
required. 
Mouse complement was nonhemolytic for both sensitized sheep and rabbit 
erythrocytes. 
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SUMMARY 
The bactericidal activity of complement was demonstrated when it 
was observed in the late nineteenth century that fresh serum was 
capable of killing bacteria. Since that time, many complement studies 
have involved its bactericidal activity. New surgical techniques and 
immunosuppressive drugs in both human and veterinary medicine have 
contributed to a rise in the frequency of gram-negative bacterial 
infections; infections that are costly in terms of time and money. 
Endotoxin, specifically LPS, is responsible for many of the symptoms 
associated with these infections. The interaction of LPS with 
complement has been well-studied in vitro to better understand in vivo 
processes. Guinea pig and human complements are most frequently used 
for in· vitro studies. Complement, though, varies from species to 
species, each having different properties. 
Three complements from domestic animals, bovine, porcine, and 
equine, were selected for the present study to determine 
susceptibility of bacterial strains to complement. In addition, three 
complements commonly used for in vitro studies, human, guinea pig, and 
mouse, were also included. The bacterial strains were selected from a 
group of ~ cholerae-suis strains previously tested. 
strains were also included. 
Two E. coli 
Part 1 of the present study examined the susceptibility of these 
strains to each complement with and without antibody. The results 
from these experiments indicated that equine, bovine, human, and 
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p::>rcine complements, in the absence of antibody, were capable.of 
killing strains susceptible to antibody and complement. Pretreatment 
of strains with Tris-EDTA enhanced the bactericidal effect of these 
complements. Few strains were susceptible to guinea pig complement; 
none were susceptible to mouse complement. 
Lip::>p::>lysaccharide activates complement by either the classical or 
alternate pathway, in the presence or absence of antibody. Reduction 
of complement levels by selected strains of bacteria were compared in 
Part 2 to determine which pathway was activated. Four complements, 
bovine, p::>rcine, human, and equine, were selected because of their 
bactericidal activity. The chelators EDTA and EGTA were used to 
selectively inhibit one or both pathways. The r,esults indicated that 
each of the four bactericidal complements were activated by the 
alternate pathway. Strains that reduced complement levels were not 
always killed by that complement. Each of the four strains consumed 
and reduced complement to approximately the same level as zymosan. 
But strain susceptibility varied for each complement. The results 
indicated that complement activation and consumption did not 
necessarily lead to bacterial killing as suggested by Joiner et al. 
(1982a,b). Strain SC33 was susceptible to both complement and heat-
inactivated complement (Part 1). Complement activation and reduction 
by this strain occurred to an extent similar to reduction by other 
strains. It is p::>ssible that other bacteriostatic or bactericidal 
factors present in serum may have affected SC33. 
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Bovine complement was reported to lyse rabbit erythrocytes in the 
presence of EGTA, indicating activation of the alternate pathway by 
the erythrocytes. Earlier reports of Linscott and Triglia (1980) and 
Triglia and Linscott (1980) indicated that 10 mM EDTA/ml C was 
insufficient to block Cl activation; thus, the classical pathway was 
responsible for hemolysis. The results of the present study have 
demonstrated that the classical pathway of bovine complement was 
blocked by all concentrations of EGTA tested, and that bovine 
complement lysed rabbit erythrocytes by the alternate pathway. 
Complement chemistry and function has been studied for many years. 
Complement serves as an important defense against infection, either 
alone or in cooperation with other immune systems. The most vital 
function of complement is the ability to kill bacteria, and though 
much work has been done, there is still much more to discover. The 
present study was an extension of the work of Griffith and Kramer 
(1982), involving the susceptibility of smooth strains of§.:_ cholerae-
suis to porcine antibody and complement. The initial objectives were 
to determine if susceptibility varied with the species of complement, 
and if complement alone was bactericidal. The results have 
demonstrated much more. Susceptibility varied for each complement, 
and some species complements, in the absence of antibody, were very 
bactericidal. Equine complement, which was the least studied 
complement, was the most bactericidal. Other unexpected results were 
the susceptibility of SC33 to heat-inactivated complement and the 
activation of the alternate pathway by erythr6cytes. 
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Early work in complement studies interchanged components from 
different species complements to determine hemolytic and bacteriolytc 
activity of complement. Later studies have indicated that components 
from some species complements are not interchangeable and that each 
complement has different properties. The variability demonstrated in 
this and other studies has.indicated that there is justification for 
examining an important immunological phenomenon such as complement 
from different animal species. 
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